investorscraft@gmail.com

Intrinsic Value of Elevance Health Inc. (ELV)

Previous Close$340.07
Intrinsic Value
Upside potential
Previous Close
$340.07

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Elevance Health Inc. operates as a leading health benefits company in the U.S., primarily serving commercial, Medicaid, Medicare, and individual markets. The company generates revenue through premium-based health insurance plans, administrative services, and pharmacy benefit management. Its diversified portfolio includes medical, dental, vision, and behavioral health services, positioning it as a comprehensive healthcare solutions provider. Elevance Health leverages scale and data analytics to optimize care delivery and cost efficiency, reinforcing its competitive edge in a highly regulated and competitive industry. The company’s integrated model combines insurance with care delivery, enabling it to capture value across the healthcare continuum. Its strong brand recognition and strategic partnerships with providers enhance its ability to attract and retain members, solidifying its market leadership. Elevance Health’s focus on value-based care and digital health innovations further differentiates it from peers, aligning with industry shifts toward preventive and personalized healthcare.

Revenue Profitability And Efficiency

Elevance Health reported $176.8 billion in revenue for FY 2024, reflecting its substantial scale in the health benefits sector. Net income stood at $6.0 billion, with diluted EPS of $25.68, indicating robust profitability. Operating cash flow of $5.8 billion underscores efficient cash generation, while capital expenditures of $1.3 billion suggest disciplined reinvestment in growth and operational capabilities.

Earnings Power And Capital Efficiency

The company’s earnings power is evident in its ability to sustain high revenue and net income levels, supported by a diversified revenue base. Capital efficiency is demonstrated by its strong operating cash flow relative to capital expenditures, enabling strategic investments and shareholder returns. The diluted EPS of $25.68 highlights effective earnings distribution across its 232.9 million outstanding shares.

Balance Sheet And Financial Health

Elevance Health maintains a solid balance sheet with $8.3 billion in cash and equivalents, providing liquidity for operations and strategic initiatives. Total debt of $31.2 billion is manageable given its cash flow generation and scale. The company’s financial health is further supported by its ability to service debt and fund growth without compromising stability.

Growth Trends And Dividend Policy

Growth trends are underpinned by Elevance Health’s expanding membership and focus on value-based care. The company’s dividend policy, with a $6.48 per share payout, reflects its commitment to returning capital to shareholders while retaining funds for reinvestment. This balanced approach supports both growth and income-oriented investors.

Valuation And Market Expectations

Elevance Health’s valuation reflects its leadership position and consistent financial performance. Market expectations are likely anchored on its ability to navigate regulatory changes and capitalize on healthcare industry trends, such as digital transformation and preventive care. The company’s scale and profitability justify its premium valuation relative to peers.

Strategic Advantages And Outlook

Strategic advantages include Elevance Health’s integrated care model, data-driven insights, and strong provider networks. The outlook remains positive, driven by demographic tailwinds, healthcare demand growth, and innovation in care delivery. The company is well-positioned to sustain its market leadership and deliver long-term value to stakeholders.

Sources

Company filings, investor presentations, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount